Aizhen Yang

Aizhen Yang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2023 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
LGLiang Gao
Liang Gao
HCHe Chao
He Chao
AYAizhen Yang
Aizhen Yang
HZHaibin Zhou
Haibin Zhou
QLQingxian Lu
Qingxian Lu
YWYi Wu
Yi Wu
Tyro3, Axl, and Mertk (abbreviated TAMs) comprise a family of homologous type 1 receptor tyrosine kinases (RTKs) that have been implicated as inhibitory receptors that dampen inflammation, but their roles in the pathogenesis of rheumatoid arthritis remains understudied. Here, to investigate TAMs in an inflammatory arthritis model, antibody-induced arthritis in single TAM-deficient mice (Tyro3- KO, Axl-KO, Mertk-KO) was induced by K/BxN serum injection. Subsequently, joint inflammation and cytokine levels, as well as the expression of Fcγ Rs and complement receptors were assessed in WT and TAM-deficient mice. Compared with littermate control mice, Axl−/− and Mertk−/− mice developed more severe antibody-induced arthritis, while in contrast, Tyro3−/− mice showed diminished joint inflammation. Concomitantly, the levels of cytokines in joints of Axl−/− and Mertk−/− mice were also significantly increased, while cytokines in the Tyro3−/− joint tissues were decreased. At the molecular and cellular level, TAMs showed distinct expression patterns, whereby monocytes expressed Axl and Mertk, but no Tyro3, while neutrophils expressed Axl and Tyro3 but little Mertk. Moreover, expression of Fcγ receptors and C5aR showed different patterns with TAMs expression, whereby FcγRIV was higher in monocytes of Axl−/− and Mertk−/− mice compared to wild-type mice, while Tyro3−/− neutrophils showed lower expression levels of FcγRI, FcγRIII and FcγRIV. Finally, expression of C5aR was increased in Mertk−/− monocytes, and was decreased in Tyro3−/− neutrophils. These data indicate that Axl, Mertk and Tyro3 have distinct functions in antibody-induced arthritis, due in part to the differential regulation of cytokines production, as well as expression of FcγRs and C5aR.

2 May 2025 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
ZZZhenzhen Zhao
Zhenzhen Zhao
YZYaqiong Zhang
Yaqiong Zhang
YCYixin Cheng
Yixin Cheng
XCXuyang Chen
Xuyang Chen
YLYi Lu
Yi Lu
AYAizhen Yang
Aizhen Yang
Membrane exposure of phosphatidylserine (PS) on platelets is critical for the binding of coagulation factors leading to coagulation activation, however, the mechanism controlling PS exposure remains largely unknown. Using genetically modified mouse models, we previously reported that a transmembrane disulfide isomerase TMX1 inhibited integrin αIIbβ3 outside-in signaling which is important for PS exposure on platelets. In this study, we investigated the role of TMX1 in PS exposure and coagulation. We found that the deficiency of TMX1 in platelets enhanced fibrin formation and PS exposure at the site of injury. In vitro, TMX1 inhibited thrombin generation mediated by activated platelets, and attenuated PS exposure on platelets, the effect of which was prevented when integrin αIIbβ3 outside-in signaling was blocked, suggesting that TMX1 inhibition of integrin αIIbβ3 outside-in signaling suppresses PS exposure. Moreover, TMX1 deficiency increased the free thiols of TMEM16 F in platelets including Cys338, Cys349 and Cys352. In HEK293 T cells overexpressing C338S-, C349S-mutated TMEM16 F, the PS exposure was increased, suggesting that TMX1 oxidizes these disulfide bonds of TMEM16 F, decreasing its activity to externalize PS on the membrane. Together, our observations for the first time demonstrate that TMX1 inhibits PS exposure in platelets downregulating the procoagulant activity, by which TMX1 plays a critical role in maintaining vascular quiescence.

18 December 2024 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
CHChao He
Chao He
AYAizhen Yang
Aizhen Yang
YZYuxin Zhang
Yuxin Zhang
ZZZhenzhen Zhao
Zhenzhen Zhao
YLYi Lu
Yi Lu
YWYi Wu
Yi Wu
Previous studies using genetically modified mouse models and inhibitors have shown that protein disulfide isomerase (PDI) family plays a significant role in arterial thrombosis. However, their role in venous thrombosis remains unknown. In this study, using gene-modified mouse models, we determined whether PDI family members contribute to venous thrombosis. Mice deficient of the PDI family members, including PDI, PDIp, ERp57, PDIr, ERp5, ERp27, ERp29, TMX4, ERdj5, and ERp18, were generated. The venous thrombosis phenotype of these deficient strains was evaluated using an inferior vena cava (IVC) stenosis model. Moreover, the recombinant human ERp18 (rhERp18) protein was generated and its reductase activity was assessed using a Di-E-GSSG method. The effect of ERp18 in venous thrombosis was tested in the IVC stenosis model. The levels of von Willebrand factor (vWF) at the site of venous thrombi were measured. The mice deficient in PDI, PDIp, ERp57, PDIr, ERp5, ERp27, ERp29, TMX4, and ERdj5 had no effects on venous thrombosis in the IVC stenosis model. However, the mice lacking ERp18 developed significantly less venous thrombosis compared with the WT mice. ERp18 contains one CGAC active motif. When WT or ERp18-KO mice received injection of rhERp18-WT or inactive rhERp18-mutant (Mut) protein whose CGAC was mutated to SGAS, rhERp18-Mut protein inhibited venous thrombosis in the IVC stenosis model, suggesting that the role of ERp18 is dependent on its enzymatic activity. As determined by enzyme-linked immunosorbent assay (ELISA) and immunofluorescence staining, the levels of vWF in the plasma at the site of venous thrombus in ERp18-KO mice were significantly lower than those in WT mice. ERp18 enhances the development of venous thrombosis, and its function and its enzymatic activity and regulation of the vWF release are involved.

7 May 2025 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
XYXiaofeng Yan
Xiaofeng Yan
YLYishan Lu
Yishan Lu
KLKeyu Lv
Keyu Lv
MJMiao Jiang
Miao Jiang
CFChao Fang
Chao Fang
AYAizhen Yang
Aizhen Yang
Several members of protein disulfide isomerase (PDI) family with the CXYC active motif such as PDI, ERp57, ERp72, ERp46, ERp5 and TMX1 have important roles in platelet functions and thrombosis. These members contribute to the network of redox regulation of platelet activities. However, whether other PDI family members without the CXYC motif such as ERp29, have a role in these processes remains unknown. To determine the role of ERp29 in platelet functions and thrombosis. The phenotypes of platelet-specific ERp29-deficient (Pf4-Cre/ERp29fl/fl) mice were evaluated using tail bleeding assay and laser-induced and FeCl3-induced arterial injury models, as well as venous thrombosis model. In vitro, the functions of ERp29-deficient platelets were assessed in respect to aggregation, adhesion, spreading, clot retraction, granule secretion and integrin αIIbβ3 activation measured by flow cytometry. Redox state of integrin αIIbβ3 thiols was detected using 3-(N-maleimido-propionyl) biotin (MPB) labeling. Compared with WT mice, Pf4-Cre/ERp29fl/fl mice exhibited shortened tail-bleeding times, increased platelet accumulation in the two arterial thrombosis models, and enhanced thrombogenesis in the venous thrombosis model. ERp29-deficient platelets had enhanced response in aggregation, ATP release, spreading, clot retraction, αIIbβ3 activation, fibrinogen binding and P-selectin expression. As detected by MPB labeling, the free thiol content of integrin αIIbβ3 in ERp29-deficient platelets were increased compared with WT platelets, suggesting that the role of ERp29 is associated with oxidation of the functional disulfides of integrin αIIb and/or β3 subunits. ERp29 is the first disulfide isomerase without the CXYC motif that negatively regulates platelet function. This study provides new insight into the redox network controlling thrombosis.

25 July 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
YZYuxin Zhang
Yuxin Zhang
YZYingkun Zhang
Yingkun Zhang
AYAizhen Yang
Aizhen Yang
YZYabei Zuo
Yabei Zuo
XYXiaofeng Yan
Xiaofeng Yan
JZJingyu Zhang
Jingyu Zhang
Von Willebrand disease (VWD) is the most common inherited bleeding disorder, yet the contribution of specific VWF domains to its pathogenesis remains incompletely understood. In particular, the role of the D4 domain in VWF secretion, intracellular maturation, and multimer formation has not been fully elucidated. Here, we investigated the functional impact of a heterozygous p.Cys2163Tyr variant located in the D4 domain, identified in a patient with a severe bleeding phenotype, using clinical evaluation, genetic analysis, family studies, and in vitro expression assays. Laboratory testing revealed markedly reduced VWF:Ag (6.8 IU/dL), VWF:GPIbR (0.1 IU/dL), and FVIII:C levels, indicating a severe VWD phenotype in the proband. Plasma VWF multimer analysis showed a markedly reduced overall VWF signal with an almost complete absence of high-molecular-weight multimers, supporting classification of the phenotype as severe type 2A VWD. The heterozygous c.6488G>A (p.Cys2163Tyr) variant was also present in asymptomatic family members, indicating incomplete segregation with the severe phenotype and suggesting that this variant alone is insufficient to explain the proband’s disease severity. Notably, the proband’s mother exhibited mildly reduced VWF levels in the absence of this variant, suggesting the possible contribution of an additional unidentified defect or modifier affecting the maternal allele. In vitro expression demonstrated preserved intracellular VWF antigen, markedly reduced secretion of mutant VWF, and loss of high-molecular-weight VWF multimers. Together, these findings indicate that VWF p.Cys2163Tyr is a functionally deleterious variant that markedly impairs VWF secretion and high-molecular-weight multimer formation in vitro. However, the incomplete segregation observed in the family suggests that this heterozygous variant alone may not fully account for the proband’s severe type 2A VWD phenotype.

31 August 2023 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
LGLiang Gao
Liang Gao
CHChao He
Chao He
AYAizhen Yang
Aizhen Yang
HZHaibin Zhou
Haibin Zhou
QLQingxian Lu
Qingxian Lu
YWYi Wu
Yi Wu